The Council has reached a political agreement on a council recommendation to adopt the European Research Area (ERA) Policy Agenda 2025–2027. The ERA policy agenda is a comprehensive roadmap for enhancing Europe’s research and innovation (R&I) ecosystem, addressing key challenges like knowledge mobility, sustainability and international competitiveness, while ensuring measurable outcomes and broad voluntary participation by Member States and stakeholders.

Priority Area 2, Taking up together the green transition and digital transformation and other challenges with impact on society, and increasing society's participation in the ERA, includes "Accelerating new approach methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices" as one of the three ERA actions proposed for the next three years.